Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMTX
#2309
Immatics N.V. - Ordinary Shares
9.5
3
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.85%
Monthly Change
+10.56%
6 month change
-5.55%
Year Change
-7.92%
Previous Close
9.4
5
Open
9.5
3
Low
9.5
3
High
9.5
3
Volume
36
Markets
US Stock Market
Healthcare
Biotechnology
IMTX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
2025
TTM
Cash from operating activities
—
—
—
0
—
—
—
Cash from investing activities
—
—
—
—
—
—
—
Cash from financing activities
—
—
—
—
—
—
—
Free cash flow
—
—
—
0
—
—
—
News
Immatics: 'Buy' On 1st Half 2027 Catalyst, Potential Label Expansion For Uveal Melanoma
Iovance Biotherapeutics: Breakout Quarter, Catalysts Ahead, And Competitor Updates (IOVA)
MRNA Advances Cancer Pipeline With New Immunotherapy Study
Immatics: PRAME Is Becoming More Than A Single-Asset Story (NASDAQ:IMTX)
Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates
ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth
Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up
RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y
Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates
All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy
NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up
Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates